Abstract Details
|
John Y. Rhee, MD, MPH
(Dana Farber Cancer Institute, Harvard Medical School)
PRESENTER |
Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from 好色先生. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society. |
| Thomas Sounack | Mr. Sounack has nothing to disclose. |
| Zachary Tentor | Mr. Tentor has nothing to disclose. |
| Joshua Davis | Mr. Davis has nothing to disclose. |
| Brigitte Durieux | Miss Durieux has nothing to disclose. |
| Paul Miller, Research Assistant | Mr. Miller has received personal compensation for serving as an employee of Hillsdale College. |
| Rameen Beroukhim, MD, PhD | An immediate family member of Dr. Beroukhim has received personal compensation for serving as an employee of Moderna. Dr. Beroukhim has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scorpion Therapeutics. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Beroukhim has stock in Takeda. Dr. Beroukhim has stock in Karyoverse Therapeutics. The institution of Dr. Beroukhim has received research support from Novartis. The institution of Dr. Beroukhim has received research support from NIH. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Ohio State University. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with DKFZ. |
| Charlotta Lindvall, MD, PhD | The institution of Dr. Lindvall has received research support from National Institutes of Health. |